Hosting the conversation

Middle East Experience

Latest News

UAE reports 2,022 new COVID-19 infections, four deaths

The United Arab Emirates recorded 2,022 new coronavirus cases, 1,731 recoveries and four deaths in the last 24 hours, state news agency WAM reported on Tuesday.For more coronavirus news, visit our dedicated page.The number of active COVID-19 cases in the country has gone up to 14,254 and total recoveries sit at 471,906, the UAE’s National Emergency Crisis and Disasters Management Authority’s (NCEMA) figures showed.The 2,022 cases were detected after 266,023 tests were carried out by the country’s health authorities.Tuesday’s numbers indicate a slight increase in the number of daily cases which were up from Monday’s 1,928 new COVID-19 cases and two deaths.The UAE’s death toll went up to 1,537, with 487,697 diagnosed cases since the beginning of the outbreak in March 2020.The country is on its way to vaccinating a large section of the population, with over 9 million doses already administered.Read more:Ramadan rules for restaurants in Dubai droppedUAE reports 1,928 new COVID-19 cases, two deathsRollout of eye-scan test for COVID-19 targeted by German firm
Source: Al Arabiya
Full Article: UAE reports 2,022 new COVID-19 infections, four deaths

US health officials halt use of Johnson & Johnson COVID-19 vaccine over clot reports

Health officials in the United States Tuesday recommended the temporary suspension of using the Johnson & Johnson coronavirus vaccine after multiple cases of blood clotting appeared in individuals who received the jab.White House COVID-19 Response Coordinator Jeff Zients said the decision was made after the FDA and CDC recommended the move “out of an abundance of caution.”Read the latest updates in our dedicated coronavirus section.So far, there have been six reported cases in the US of a “rare and severe type of blood clot in individuals after receiving the Johnson & Johnson vaccine,” Zients said.But the pause in J&J’s vaccine will not have a significant impact on the US vaccination plan. Zients said the company’s vaccine made up less than 5 percent of the recorded shots given in the US.The six blood clots were reported out of almost seven million J&J doses given since April 12.The CDC later said that no blood clots were seen in almost 200 million doses of the Pfizer and Modera vaccines.Zients said there was more than enough supply to “continue the current pace of vaccinations of 3 million shots per day and meet the President’s goal of 200 million shots by his 100th day in office.”He added that those scheduled to receive a J&J vaccine would be rescheduled for the Pfizer or Moderna jab.It is worth noting that the J&J vaccine uses an adenovirus vector, which is the same technology used in vaccines made by companies in China, Russia and the United Kingdom. AstraZeneca has faced several setbacks after blood clots were widely reported in individuals who received its vaccines.Adenovirus vector is not new, and it was used in the Ebola vaccine approved by the FDA years ago.Pfizer and Moderna use mRNA technology, which does not contain a live virus.Read more: Johnson & Johnson’s COVID-19 vaccine under EU review over blood clots
Source: Al Arabiya
Full Article: US health officials halt use of Johnson & Johnson COVID-19 vaccine over clot reports